ILLUMINA INC · held by 2 funds · data as of 2026-06-03
Sector
Healthcare
Industry
Diagnostics & Research
Market cap
$24.59B
Price
$169.22
12-mo
+104.70%
P/E
30.8
Held by
2 funds
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenat…